Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
filingDate |
1982-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cd00262dd91d2bc6b139de93d9777fa |
publicationDate |
1983-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
FR-2516087-A1 |
titleOfInvention |
5A-CHOLESTANE-3B, 22S-DIOLS SUBSTITUTED IN POSITION 25 AND THEIR ESTERS, AND THEIR THERAPEUTIC USES AS BIOSYNTHESIS INHIBITORS OF CHOLESTEROL |
abstract |
CHOLESTANE DERIVATIVES AND THEIR THERAPEUTIC USES. THESE COMPOUNDS MEET THE FORMULA: (CF DESIGN IN BOPI) IN WHICH R AND R H OR RADICAL ESTERIFYING FORMULA: (CF DESIGN IN BOPI) N1 A 3 AND RHALOGEN OR ALKYL IN C-C. THESE COMPOUNDS INHIBIT BIOSYNTHESIS OF CHOLESTEROL AND CAN THEREFORE BE USED THERAPEUTICALLY. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019076269-A1 |
priorityDate |
1981-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |